David M. Goldstein - 29 Jul 2025 Form 4 Insider Report for ALUMIS INC. (ALMS)

Role
Chief Scientific Officer
Signature
/s/ Sanam Pangali, Attorney-in-Fact
Issuer symbol
ALMS
Transactions as of
29 Jul 2025
Transactions value $
$0
Form type
4
Filing time
31 Jul 2025, 21:05:12 UTC
Previous filing
20 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldstein David M Chief Scientific Officer C/O ALUMIS INC., 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO /s/ Sanam Pangali, Attorney-in-Fact 31 Jul 2025 0001751719

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALMS Common Stock Award $0 +27K +1276.6% $0.00 29.1K 29 Jul 2025 Direct F1, F2
holding ALMS Common Stock 208K 29 Jul 2025 By Trust F3
holding ALMS Common Stock 8.99K 29 Jul 2025 By Family Members F4
holding ALMS Common Stock 1K 29 Jul 2025 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALMS Stock Option (Right to Buy) Award $0 +108K $0.00 108K 29 Jul 2025 Common Stock 108K $3.95 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. 25% of the shares underlying this RSU vest on August 1, 2026, and the remaining shares vest in equal quarterly installments thereafter over the following 12 quarters, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.
F2 Includes 2,115 shares acquired on May 20, 2025 under the Issuer's 2024 Employee Stock Purchase Plan.
F3 Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.
F4 Shares are held directly by family members of Reporting Person residing in his primary residence.
F5 Shares are held directly by the Jacqueline Goldstein Trust dated September 17, 2019, for which the Reporting Person serves as trustee. Reporting Person became trustee on March 26, 2025 in a transaction that was exempt from reporting.
F6 25% of the shares underlying this option vest on July 29, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.